Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000794325 | SCV000933725 | benign | Tuberous sclerosis 2 | 2023-10-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002458416 | SCV002618239 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-11-19 | criteria provided, single submitter | clinical testing | The p.S1130A variant (also known as c.3388T>G), located in coding exon 28 of the TSC2 gene, results from a T to G substitution at nucleotide position 3388. The serine at codon 1130 is replaced by alanine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |